Jeff Yass’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-11,400
Closed -$39.9K – 13111
2025
Q4
$39.9K Buy
+11,400
New +$39.8K ﹤0.01% 11822
2022
Q4
– Sell
-10,500
Closed -$47K – 12331
2022
Q3
$47K Sell
10,500
-11,400
-52% -$81.6K ﹤0.01% 12238
2022
Q2
$128K Buy
+21,900
New +$112K ﹤0.01% 11216
2019
Q2
– Sell
-11,700
Closed -$74K – 10172
2019
Q1
$74K Buy
+11,700
New +$90.5K ﹤0.01% 8357
2017
Q4
– Sell
-13,400
Closed -$45K – 9193
2017
Q3
$45K Buy
+13,400
New +$34.6K ﹤0.01% 8560
2017
Q2
– Sell
-15,400
Closed -$41K – 9145
2017
Q1
$41K Buy
+15,400
New +$51.1K ﹤0.01% 8629

Other funds holding APYX

Jeff Yass's APYX Position: Q3 2026 in Review

Jeff Yass reduced its Apyx Medical (APYX) stake by 17% in Q3 2026, selling an estimated $131K and leaving 178,873 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #10098.

Jeff Yass first reported a position in APYX in Q1 2016 and has held it in 25 quarters since. The position peaked at $1.3M in Q1 2019. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2026.

  • Jeff Yass held 178,873 shares of Apyx Medical worth $438K as of Q3 2026.
  • Jeff Yass sold 37,390 Apyx Medical shares in Q3 2026, an estimated $131K.
  • Apyx Medical made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10098 holding.
  • Jeff Yass first reported a position in Apyx Medical in Q1 2016 and has held it in 25 quarters since.
  • Jeff Yass's Apyx Medical position peaked at $1.3M in Q1 2019.
  • 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.